ישראל - עברית - Ministry of Health

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - תמיסה לדיאליזה פריטוניאלית - magnesium chloride 0.1017 g; calcium chloride 0.1838 g; glucose as monohydrate 16.5 g; lactic acid as sodium 3.925 g; sodium chloride 5.786 g - combinations - combinations - for use in patients with end-stage (decompersated )chronic renal failure of any origin which can be treated with peritoneal dealysis.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - clobetasol 17- propionate - משחה - clobetasol 17- propionate 0.05 %w/w - clobetasol - clobetasol - resistant dermatoses responsive to potent corticosteroid therapy.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - clobetasol 17- propionate - קרם - clobetasol 17- propionate 0.05 %w/w - clobetasol - clobetasol - resistant dermatoses responsive to potent corticosteroid therapy.

ישראל - עברית - Ministry of Health

דניה קוסמטיקס בעמ - איפור עיניים

ישראל - עברית - Ministry of Health

פרמייר ים המלח מעבדות קוסמטיקס בעמ - הזנה לפנים

ישראל - עברית - Ministry of Health

זהר קוסמטיקס (מ.עו.פ) בעמ - לחות לפנים

ישראל - עברית - Ministry of Health

זהר קוסמטיקס (מ.עו.פ) בעמ - לחות לפנים

ישראל - עברית - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - איפור

ישראל - עברית - Ministry of Health

שולמית קוסמטיקה ואירוסול (1999) בעמ - טיפוח עור הגוף

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - atorvastatin as calcium - טבליות מצופות פילם - atorvastatin as calcium 40 mg - atorvastatin - atorvastatin - lipitor is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. lipitor is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190